2015 Medscheme Billing Changes

2015 Medscheme Billing Perspective Change:

Scheme Rate

Whereas in the past, claims were submitted REPI1 and REPI3, Medscheme have now requested that consultations (0190) be submitted at the “Scheme Rate”.

Medscheme Medical Schemes:

  • AECI
  • Bonitas
  • Fedhealth
  • Glencore
  • MBMED
  • Sasolmed

 

Medscheme themselves will add the enhanced fee.

**************************

E.g.

Practice submits AECI claim 0190 at R303.70

For a REPI1 practice, remittance will show payment of R303.70 in your favour PLUS an enhanced fee in the comment line of R91.10 –  total payment therefore R394.48

Click here to get 2015 Medinol Medical Tariffs

.

++++++++++++++++++++++++++++++++

Would you love to Subscribe and be kept updated?

Please fill out your details below:

Your Name (required)

Your Email (required)

Telephone No. (required)

Practice No. (required)

Specialty (required)

++++++++++++++++++++++++++++++++

 

*********************************************************

About Medinol:
Medinol is one of the few purpose-built practice management application to meet the unique needs of independent private healthcare providers. Today Medinol helps over 130 providers throughout South Africa run more efficient and profitable practices, while delivering outstanding patient care. As an on-premise software, Medinol and the data it manages, is fully under your control. This enhances your independence and privacy: what happens in your rooms, stays in your rooms. Medinol helps manage your patient information, generates your billings, submits your claims, control your outstandings, and get your accounts paid quickly. Medinol has been in operation since 1984 demonstrating its proven efficacy. Medinol’s mission is to help independent practices succeed in an ever-changing healthcare environment. More information can be found at http://medinol.co.za.

Contact:

medical billing software

 

Fudley Bezuidenhout Pr.Eng.
Founder and CEO
Email: info@medinol.co.za
Ph: 021-906-2296
Cell: 082-688-9610

*********************************************************